Malaysian Genomics Resource (0155) - Net Assets

Latest as of December 2025: RM15.77 Million MYR ≈ $3.96 Million USD

Based on the latest financial reports, Malaysian Genomics Resource (0155) has net assets worth RM15.77 Million MYR (≈ $3.96 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (RM18.71 Million ≈ $4.70 Million USD) and total liabilities (RM2.94 Million ≈ $736.88K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read 0155 liabilities breakdown for a breakdown of total debt and financial obligations.

Key Net Assets Metrics

Metric	Value
Current Net Assets	RM15.77 Million
% of Total Assets	84.31%
Annual Growth Rate	0.28%
5-Year Change	1.26%
10-Year Change	-6.37%
Growth Volatility	45.22

Malaysian Genomics Resource - Net Assets Trend (2015–2025)

This chart illustrates how Malaysian Genomics Resource's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Malaysian Genomics Resource for the complete picture of this company's asset base.

Annual Net Assets for Malaysian Genomics Resource (2015–2025)

The table below shows the annual net assets of Malaysian Genomics Resource from 2015 to 2025. For live valuation and market cap data, see 0155 market cap.

Year	Net Assets	Change
2025-06-30	RM18.16 Million ≈ $4.56 Million	-18.76%
2024-06-30	RM22.35 Million ≈ $5.61 Million	-16.58%
2023-06-30	RM26.79 Million ≈ $6.73 Million	-27.69%
2022-06-30	RM37.05 Million ≈ $9.30 Million	+106.62%
2021-06-30	RM17.93 Million ≈ $4.50 Million	+74.79%
2020-06-30	RM10.26 Million ≈ $2.58 Million	-35.61%
2019-06-30	RM15.93 Million ≈ $4.00 Million	-19.42%
2018-06-30	RM19.77 Million ≈ $4.96 Million	-18.66%
2017-06-30	RM24.30 Million ≈ $6.10 Million	+25.34%
2016-06-30	RM19.39 Million ≈ $4.87 Million	+9.85%
2015-06-30	RM17.65 Million ≈ $4.43 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Malaysian Genomics Resource's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 3644947000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component	Amount	Percentage
Common Stock	RM59.44 Million	327.37%
Total Equity	RM18.16 Million	100.00%

Malaysian Genomics Resource Competitors by Market Cap

The table below lists competitors of Malaysian Genomics Resource ranked by their market capitalization.

Company	Market Cap
LCK Global Kedaton JK:LCKM	$9.67 Million
Mint Incorporation Limited Class A Ordinary Shares NASDAQ:MIMI	$9.68 Million
Alpha Modus Holdings, Inc NASDAQ:AMOD	$9.68 Million
Titan Logix Corp. V:TLA	$9.69 Million
Baru Gold Corp V:BARU	$9.66 Million
Onelife Capital Advisors Limited NSE:ONELIFECAP	$9.66 Million
CLASS 1 NICKEL+TECH.LTD F:77C	$9.66 Million
Sahathai Terminal Public Company Limited BK:PORT	$9.65 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Malaysian Genomics Resource's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 22,346,760 to 18,155,360, a change of -4,191,400 (-18.8%).
Net loss of 4,191,390 reduced equity.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	RM-4.19 Million	-23.09%
Other Changes	RM-10.00	-0.0%
Total Change	RM-	-18.76%

Book Value vs Market Value Analysis

This analysis compares Malaysian Genomics Resource's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.93x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has increased from 1.24x to 1.93x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-06-30	RM0.21	RM0.26	x
2017-06-30	RM0.23	RM0.26	x
2018-06-30	RM0.19	RM0.26	x
2019-06-30	RM0.15	RM0.26	x
2020-06-30	RM0.10	RM0.26	x
2021-06-30	RM0.15	RM0.26	x
2022-06-30	RM0.30	RM0.26	x
2023-06-30	RM0.21	RM0.26	x
2024-06-30	RM0.16	RM0.26	x
2025-06-30	RM0.13	RM0.26	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Malaysian Genomics Resource utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -23.09%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -75.90%
• Asset Turnover: 0.25x
• Equity Multiplier: 1.23x
Recent ROE (-23.09%) is below the historical average (-2.31%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2015	20.53%	26.07%	0.64x	1.23x	RM1.86 Million
2016	8.97%	16.67%	0.49x	1.11x	RM-200.32K
2017	2.42%	5.97%	0.26x	1.56x	RM-1.84 Million
2018	-22.94%	-17.34%	0.64x	2.07x	RM-6.51 Million
2019	-24.10%	-1356.55%	0.01x	2.32x	RM-5.43 Million
2020	166.70%	1797.48%	0.09x	1.08x	RM16.07 Million
2021	-23.94%	-240.70%	0.08x	1.27x	RM-6.09 Million
2022	19.46%	25.43%	0.68x	1.13x	RM3.51 Million
2023	-53.18%	-170.33%	0.27x	1.15x	RM-16.92 Million
2024	-96.28%	-167.30%	0.50x	1.15x	RM-23.75 Million
2025	-23.09%	-75.90%	0.25x	1.23x	RM-6.01 Million

Industry Comparison

This section compares Malaysian Genomics Resource's net assets metrics with peer companies in the Diagnostics & Research industry.

No peer company data available for comparison.

About Malaysian Genomics Resource

KLSE:0155 Malaysia Diagnostics & Research

Market Cap

$9.66 Million

RM38.49 Million MYR

Market Cap Rank

#27103 Global

#856 in Malaysia

Share Price

RM0.26

Change (1 day)

-1.92%

52-Week Range

RM0.17 - RM0.26

All Time High

RM2.72